Nilutamide

尼鲁米特

Report date: 2026/04/25 20:00:23
NME

Base Information

Drug NameNilutamide
Drug Alias Name尼鲁胺nilutamidenilutamida尼鲁特米里奴内酰胺 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date1987/01/01
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanz Pharma Ltd
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL02BB02
Related LinksWikipediaDrugBankKEGG